<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Low Dose Lung CT Screening in an Asian Population" /><meta property="og:locale" content="en" /><meta name="description" content="In the current edition of Academic Radiology, Hsu et al. ( ) evaluate potential improvement in the detection of lesions in the spectrum of adenocarcinoma (LSAs) by first proposing modifications of current ACR Lung-RADS criteria and then retrospectively applying these to a screened cohort of Asian individuals including both ever and never-smokers, between 40 and 80years of age. The authors’ contention is that by broadly expanding the number of eligible individuals for screening while simultaneously focusing on the most suspicious lesions, identifying adenocarcinomas will be significantly increased necessitating a reappraisal of current management guidelines." /><meta property="og:description" content="In the current edition of Academic Radiology, Hsu et al. ( ) evaluate potential improvement in the detection of lesions in the spectrum of adenocarcinoma (LSAs) by first proposing modifications of current ACR Lung-RADS criteria and then retrospectively applying these to a screened cohort of Asian individuals including both ever and never-smokers, between 40 and 80years of age. The authors’ contention is that by broadly expanding the number of eligible individuals for screening while simultaneously focusing on the most suspicious lesions, identifying adenocarcinomas will be significantly increased necessitating a reappraisal of current management guidelines." /><link rel="canonical" href="https://clinicaltree.github.io/posts/low-dose-lung-ct-screening-in-an-asian-population/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/low-dose-lung-ct-screening-in-an-asian-population/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2018-09-30T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Low Dose Lung CT Screening in an Asian Population" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T03:59:08+00:00","datePublished":"2018-09-30T17:00:00+00:00","description":"In the current edition of Academic Radiology, Hsu et al. ( ) evaluate potential improvement in the detection of lesions in the spectrum of adenocarcinoma (LSAs) by first proposing modifications of current ACR Lung-RADS criteria and then retrospectively applying these to a screened cohort of Asian individuals including both ever and never-smokers, between 40 and 80years of age. The authors’ contention is that by broadly expanding the number of eligible individuals for screening while simultaneously focusing on the most suspicious lesions, identifying adenocarcinomas will be significantly increased necessitating a reappraisal of current management guidelines.","headline":"Low Dose Lung CT Screening in an Asian Population","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/low-dose-lung-ct-screening-in-an-asian-population/"},"url":"https://clinicaltree.github.io/posts/low-dose-lung-ct-screening-in-an-asian-population/"}</script><title>Low Dose Lung CT Screening in an Asian Population | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Low Dose Lung CT Screening in an Asian Population</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Low Dose Lung CT Screening in an Asian Population</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1538326800" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Sep 30, 2018 </em> </span> <span> Updated <em class="" data-ts="1681099148" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">David P. Naidich MD FACR FACCP</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1486 words"> <em>8 min</em> read</span></div></div></div><div class="post-content"><p>In the current edition of Academic Radiology, Hsu et al. ( ) evaluate potential improvement in the detection of lesions in the spectrum of adenocarcinoma (LSAs) by first proposing modifications of current ACR Lung-RADS criteria and then retrospectively applying these to a screened cohort of Asian individuals including both ever and never-smokers, between 40 and 80years of age. The authors’ contention is that by broadly expanding the number of eligible individuals for screening while simultaneously focusing on the most suspicious lesions, identifying adenocarcinomas will be significantly increased necessitating a reappraisal of current management guidelines.</p><p>For this purpose, an Asian cohort of 1978 individuals (including 72.8% never-smokers), were retrospectively evaluated comparing criteria from the National Lung Screening Trial (NLST) ( ) and ACR Lung-RADS to modified Lung-RADS criteria ( ) as follows: Lung-RADS categories 2 and 3 were reclassified into subcategories 2A/B/C and 3A/B/C, respectively, with 2C defined as pure groundglass nodules &lt;20mm, and 3B defined as part solid lesions ≥6mm with solid components &gt;6mm, without altering morphologic characteristics ( ). Using 2C as a cut-off then, modified Lung-RADS criteria proved to have greater predictive ability for identifying LSAs compared to either NLST or current Lung-RADS criteria ( <em>p</em> &lt; .001) with sensitivity of 100% (95% CI 89.1%, 100%), specificity of 89.3% (95% CI 87.9%, 90.6%) and an area under the curve (AUC) of 0.973 (95% CI 0.965–0.980), respectively.</p><p>Similarly, using 3B as a cut-off resulted in an improved sensitivity of 95.0% (95% CI 75.1%, 99.9%), and specificity of 97.8% (95% CI 97.1%, 98.4%) for detecting invasive adenocarcinomas (IAs). While the AUC of .992, (95% CI 0.987–0.995) proved superior to the AUC using NLST criteria, however, no significant difference was noted comparing the current AUC of Lung-RADS to modified Lung-RADS criteria ( <em>p</em> = .155).</p><p>The authors’ findings are of considerable interest and clearly provocative, however numerous questions arise specifically as to what relates to the current Western Low-dose computed tomorgraphy (LDCT) screening programs, especially to ACR- Lung-RADS. What is the impact of these data on current LDCT screening protocols? What are the implications for the management of earlier “indolent” lesions in the adenocarcinoma spectrum—especially 2C/pure groundglass nodules including atypical adenomatous hyperplasia (AAH), adenocarcinoma-in-situ (AIS) and minimally invasive adenocarcinoma (MIA)? What of the inclusion of never-smokers as represented in nearly two-thirds of the present study? Finally, what are the implications for incidentally identified nodules among high prevalence populations evaluated outside screening programs?</p><p>To answer these questions one requires further evaluation of the author’s findings ( ). Of 1978 individuals screened, 166 (8.3%) had nodules classified as 2C of which only 11 (6.6%) had documented LSAs, while only 7 (0.35%) individuals had nodules classified as 3B of which only 2 (28.5%) proved to have LSAs. Of 36 subjects with documented biopsies, four proved to have benign lesions: all the remaining 32 cases (including 30 nonsmokers) proved to be LSAs, subsequently followed for an average of only 1.6 +/− 0.5years. Of these only 20 (62.5%) proved to be IAs <em>.</em> More importantly <em>,</em> of 11 2C lesions (&lt;20 cm) fewer than half, 5 (45.5%), were interpreted as invasive cancers, although this included four MIAs. Of the remaining six cases, there were three cases each of AAH and AIS respectively. Importantly, all 11 2C cases proved to be stage 1 lesions <em>.</em></p><p>These results indicate that even in high prevalence populations the overall number of early stage lesions remains exceedingly small, consistent with numerous prior screening studies in the United States, Europe, and Asia, in part limiting concern of their overall clinical impact ( ). As important, the author’s proposed modifications fail to improve reliable differentiation among earlier stage lesions, a problem seriously compounded by the indication for complete surgical resection to diagnose AIS or MIA ( ). Also pertinent is the lack of specified indications for obtaining biopsies.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Hsu H-T, Tang E-K, Wu M-T, et. al.: Modified lung-RADS improves performance of screening LDCT in a population of non-smoking-related lung cancer. Acad Radiol 2018; 25: pp. 1240-1251.</p><li><p>2. Aberle DR, Adams AM, Berg CD, et. al.: Reduced lung-cancer mortality with low-dose computed tomographic screening. NEJM 2011; 365: pp. 395-409.</p><li><p>3. ACR, ACoR. Lung cancer screening reporting and data system (Lung RADS).</p><li><p>4. Jemal A, Fedewa SA: Lung cancer screening with low-dose computed tomography in the United States- 2010-2015. JAMA Oncol 2017; 3: pp. 1278-1281.</p><li><p>5. Kobayashi Y, Mitsudomi T, Sakao Y, et. al.: Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth. Ann Oncol 2015; 26: pp. 156-161.</p><li><p>6. Pinsky PF, Gierada DS, Black W, et. al.: Performance of lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Int Med 2015; 162: pp. 485-491.</p><li><p>7. Travis WD, Brambilla E, Noguchi M, et. al.: International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011; 6: pp. 244-285.</p><li><p>8. Noguchi M, Morikawa A, Kawasaki M, et. al.: Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995; 75: pp. 2844-2852.</p><li><p>9. Kakinuma R, Noguchi M, Ashizawa K, et. al.: Natural history of pulmonary subsolid nodules: a prospective multicenter study. J Thorac Oncol 2017; 11: pp. 1012-1028.</p><li><p>10. Matsuguma H, Mori K, Nakahara R, et. al.: Characteristics of subsolid pulmonary nodules showing growth during follow-up with CT scanning. Chest 2013; 143: pp. 436-443.</p><li><p>11. Yip R, Yankelevitz DF, Hu M, et. al.: Lung cancer deaths in the National Lung Screening Trail attributed to nonsolid nodules. Radiology 2016; 281: pp. 589-596.</p><li><p>12. Migliore M, Fornito M, Palzzolo M, et. al.: Ground glass opacities management in the lung cancer screening era. Ann Transl Med 2018; 6: pp. 90-97.</p><li><p>13. Bankier AA, MacMahon H, Goo JM, et. al.: Recommendations for measuring pulmonary nodules at CT: a statement from the Fleischner Society. Radiology 2017; 285: pp. 584-600.</p><li><p>14. Peikert T, Duan F, Rajagopaian S, et. al.: Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial. PLoS One 2018; 13: pp. e0196910. doi: 10.1371/journal.pone.0196910. Published online 2018 May 14</p><li><p>15. Rizzo S, Petreeela F, Buscarino V, et. al.: CT radiogenomic characterization of EGFR, K-RAS, and ALK mutations in non-small cell lung cancer. Eur Radiol 2016; 26: pp. 32-42.</p><li><p>16. Suzuki K, Watanabe S, Mizusawa J, et. al.: Predictors of non-neoplastic lesions in lung tumors showing ground-glass opacity on thin-section computed tomography based on a multiinsitutional prospective study. Interact Cardiovasc Thoracic Surg 2015; 21: pp. 218-223.</p><li><p>17. ten Haaf K, van der Aalst CM, de Koning MJ: Clinically detected non-aggressive lung cancers: impliations for overdiagnosis and overtreatment in lung cancer screening. Thorax 2018; 73: pp. 407-408.</p><li><p>18. ten Haaf K, de Koning HJ: Should never-smokers at increased risk for lung cancer be screened?. J Thorac Oncol 2015; 10: pp. 1285-1291.</p><li><p>19. Pham D, Bhandan S, Oechsli M, et. al.: Lung cancer screening rates: data from the lung cancer screening registry.ASCO2018 Annual Meeting.2018.</p><li><p>20. Gould MK, Tang T, Liu I, et. al.: Recent trends in the identification of incidental pulmonary nodules. Am J Resp Crit Care Med 2015; 192: pp. 1208-1214.</p><li><p>21. Baldwin DR, Callister MEJ: The British Thoracic Society guidelines on the investigation and management of pulmonary nodules. Thorax 2015; 70: pp. 794-798.</p><li><p>22. MacMahon H, Naidich DP, Goo JM, et. al.: Guidelines for management of incident pulmonary nodules detected on CT images. From the Fleischner Society. Radiology 2017; 284: pp. 228-243.</p><li><p>23. Wood DE, Kazerooni EA, Baum SL, et. al.: Lung cancer screening, Version 3.2018. JNCCN- J Natl Compr Cancer Netw 2018; 16: pp. 412-441.</p><li><p>24. Ko SJ, Lee YJ, Park JS, et. al.: Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity. BMC Cancer 2014; 14: pp. 312.</p><li><p>25. Schneider F, Smith MA, et. al.: Adequacy of core needle biopsy specimens and fine-needle aspirates for molecular testing of lung adenocarcinomas. Am J Clin Path 2015; 143: pp. 193-200.</p><li><p>26. Tsai EB, Pomykala K, Ruchalski K, et. al.: Feasibility and safety of intrathoracic biopsy and repeat biopsy for evaluation of programmed cell death ligand-1 expression for immunotherapy in non-small cell lung cancer. Radiology 2017; 287: pp. 326-332.</p><li><p>27. Silvestri GA, Tanner NT, Kearney P, et. al.: Assessment of plasma proteomics biomarker’s ability to distinguish benign from malignant lung nodules: results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) trail. Chest 2018; doi: 10.1016/j.chest.2018.02.012. pii: S0012-3692(18)30307-6. [Epub ahead of print]</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-25/'>Volume 25</a>, <a href='/categories/issue-10/'>Issue 10</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Low%20Dose%20Lung%20CT%20Screening%20in%20an%20Asian%20Population%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Flow-dose-lung-ct-screening-in-an-asian-population%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Low%20Dose%20Lung%20CT%20Screening%20in%20an%20Asian%20Population%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Flow-dose-lung-ct-screening-in-an-asian-population%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Flow-dose-lung-ct-screening-in-an-asian-population%2F&text=Low%20Dose%20Lung%20CT%20Screening%20in%20an%20Asian%20Population%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/advanced-modeled-iterative-reconstruction-admire-facilitates-radiation-dose-reduction-in-abdominal/"><div class="card-body"> <em class="small" data-ts="1538326800" data-df="ll" > Sep 30, 2018 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Advanced Modeled Iterative Reconstruction (ADMIRE) Facilitates Radiation Dose Reduction in Abdominal CT</h3><div class="text-muted small"><p> Rationale and Objectives This study aimed to determine the potential degree of radiation dose reduction achievable using Advanced Modeled Iterative Reconstruction (ADMIRE) in abdominal computed to...</p></div></div></a></div><div class="card"> <a href="/posts/building-a-tree-from-the-leaves-down-a-challenge-for-contemporary-educators/"><div class="card-body"> <em class="small" data-ts="1538326800" data-df="ll" > Sep 30, 2018 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Building a Tree From the Leaves Down A Challenge for Contemporary Educators</h3><div class="text-muted small"><p> We know a radiology resident who failed the American Board of Radiology’s core exam. In preparing for the exam the first time, he read textbooks, took cases at board review sessions, and worked thr...</p></div></div></a></div><div class="card"> <a href="/posts/characterization-of-urinary-stone-composition-by-use-of-whole-body-photon-counting-detector-ct/"><div class="card-body"> <em class="small" data-ts="1538326800" data-df="ll" > Sep 30, 2018 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Characterization of Urinary Stone Composition by Use of Whole-body, Photon-counting Detector CT</h3><div class="text-muted small"><p> Rational and Objectives This study aims to investigate the performance of a whole-body, photon-counting detector (PCD) computed tomography (CT) system in differentiating urinary stone composition....</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/investigation-of-fmri-analysis-method-to-visualize-the-difference-in-the-brain-activation-timing/" class="btn btn-outline-primary" prompt="Older"><p>Investigation of fMRI Analysis Method to Visualize the Difference in the Brain Activation Timing</p></a> <a href="/posts/magnetic-resonance-imaging-parameters-in-predicting-the-treatment-outcome-of-high-intensity-focused/" class="btn btn-outline-primary" prompt="Newer"><p>Magnetic Resonance Imaging Parameters in Predicting the Treatment Outcome of High-intensity Focused Ultrasound Ablation of Uterine Fibroids With an Immediate Nonperfused Volume Ratio of at Least 90%</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
